About Vitara Biomedical
Vitara Biomedical is a company based in Philadelphia (United States) founded in 1999.. Vitara Biomedical has raised $124.99 million across 2 funding rounds from investors including Khosla Ventures, Sands Capital and Google Ventures. Vitara Biomedical offers products and services including Platform Therapy for Preterm Infants and Velocity TM pAVF System.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vitara Biomedical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$124.99 M (USD)
in 2 rounds
-
Latest Funding Round
$50 M (USD), Series C
Oct 11, 2024
-
Investors
Khosla Ventures
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vitara Biomedical
Vitara Biomedical offers a comprehensive portfolio of products and services, including Platform Therapy for Preterm Infants and Velocity TM pAVF System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers stable environment for premature babies to develop post-birth
Reduces reinterventions for fistula maturation in vascular procedures
Unlock access to complete
Funding Insights of Vitara Biomedical
Vitara Biomedical has successfully raised a total of $124.99M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $50.0M
-
First Round
First Round
(19 Jul 2022)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series C - Vitara Biomedical | Valuation | Sands Capital | |
| Jul, 2022 | Amount | Series C - Vitara Biomedical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vitara Biomedical
Vitara Biomedical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Khosla Ventures, Sands Capital and Google Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate backed venture capital fund investing in multiple sectors
|
Founded Year | Domain | Location | |
|
A venture capital fund focused on deep tech innovations is managed.
|
Founded Year | Domain | Location | |
|
Flerie is engaged in investing in biotech and pharmaceutical companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vitara Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vitara Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vitara Biomedical Comparisons
Competitors of Vitara Biomedical
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vitara Biomedical
Frequently Asked Questions about Vitara Biomedical
When was Vitara Biomedical founded?
Vitara Biomedical was founded in 1999 and raised its 1st funding round 23 years after it was founded.
Where is Vitara Biomedical located?
Vitara Biomedical is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Who is the current CEO of Vitara Biomedical?
James S Mcglone is the current CEO of Vitara Biomedical.
Is Vitara Biomedical a funded company?
Vitara Biomedical is a funded company, having raised a total of $124.99M across 2 funding rounds to date. The company's 1st funding round was a Series C of $74.99M, raised on Jul 19, 2022.
What does Vitara Biomedical do?
Vitara Biomedical was founded in 1999 and is headquartered in Philadelphia, United States. Operations focus on the biomedical sector, where neonatal care services are provided to support infant health. These services encompass medical and support interventions for newborns, primarily within the local and national geography. Leadership is held by CEO James S Mcglone, overseeing activities in this specialized field.
What products or services does Vitara Biomedical offer?
Vitara Biomedical offers Platform Therapy for Preterm Infants and Velocity TM pAVF System.
Who are Vitara Biomedical's investors?
Vitara Biomedical has 5 investors. Key investors include Khosla Ventures, Sands Capital, Google Ventures, First Spark Ventures, and Flerie.